Assessment of Outcomes in Septic Shock and Severe Sepsis Patients with Early Critical Care...
-
Upload
conrad-ray -
Category
Documents
-
view
221 -
download
2
Transcript of Assessment of Outcomes in Septic Shock and Severe Sepsis Patients with Early Critical Care...
Assessment of Outcomes in Septic Shock and Severe
Sepsis Patients with Early Critical Care Intervention
A Case Comparison Study
Kenmore Mercy Hospital, Buffalo, NY
Matthew Missert DO
Gopichand Pendurti MBBS
Thomas Brewer DO
Background & Rationale
Severe sepsis and septic shock are characterized by a Severe sepsis and septic shock are characterized by a systemic inflammatory state secondary to an infectious systemic inflammatory state secondary to an infectious cause with evidence of end-organ damage or hemodynamic cause with evidence of end-organ damage or hemodynamic instabilityinstability
In the United States there are an estimated In the United States there are an estimated 215,000215,000 deaths deaths annually as a result of severe sepsis and septic shockannually as a result of severe sepsis and septic shock
In the past, despite heroic measures septic shock and severe In the past, despite heroic measures septic shock and severe sepsis have carried a staggering mortality rate of sepsis have carried a staggering mortality rate of 40 to 50 40 to 50 percentpercent
Surviving Sepsis Campaign: http://www.survivingsepsis.org. 2012.
Background & Rationale
Shapiro N, Howell MD, Talmor D. Implementation and Outcomes of the Multiple Urgent Sepsis Therapies (MUST) Protocol.
Critical Care Medicine. 2006. 34(4), 1025-32.
Newer methods of treatment such as Newer methods of treatment such as those described by Rivers et. al. (Early those described by Rivers et. al. (Early Goal-directed Therapy) have Goal-directed Therapy) have demonstrated a 28-day reduction in demonstrated a 28-day reduction in mortality from mortality from 49.2 to 33.3 percent
Comparable results have been observed Comparable results have been observed with similar protocols placing emphasis on with similar protocols placing emphasis on urgency and appropriateness of treatment urgency and appropriateness of treatment
Background & Rationale
Rivers E, Nguyen B, Havstad S, et al. Rivers E, Nguyen B, Havstad S, et al. Early Goal-directed Therapy in the Treatment of Severe Sepsis Early Goal-directed Therapy in the Treatment of Severe Sepsis and Septic Shock. and Septic Shock. New England Journal of MedicineNew England Journal of Medicine. 2001; 345(19), 1368-1377.. 2001; 345(19), 1368-1377.
Background & Rationale
The Society of Critical Care Medicine in conjunction The Society of Critical Care Medicine in conjunction with the European Society of Intensive Care with the European Society of Intensive Care Medicine have established recommendations for Medicine have established recommendations for the management of severe sepsis and septic shockthe management of severe sepsis and septic shock
The The Surviving Sepsis CampaignSurviving Sepsis Campaign was established to was established to standardize the classification, diagnosis and standardize the classification, diagnosis and treatment protocols treatment protocols
The latest recommendations were released in The latest recommendations were released in 2008
Surviving Sepsis Campaign: http://www.survivingsepsis.org. 2012.
Background & Rationale In summary, the In summary, the Surviving Sepsis CampaignSurviving Sepsis Campaign resuscitation bundle recommends the resuscitation bundle recommends the
following be completed within the first 6 hours of diagnosis:following be completed within the first 6 hours of diagnosis:
1.1. ICU admissionICU admission
2.2. Measurement of serum lactate within the first hourMeasurement of serum lactate within the first hour
3.3. Fluid resuscitation to achieve a CVP of ≥ 8 mmHg (≥ 12 mmHg in Fluid resuscitation to achieve a CVP of ≥ 8 mmHg (≥ 12 mmHg in mechanically ventilated patients) mechanically ventilated patients)
4.4. Maintenance of MAP ≥ 65 with the use of vasopressors if neededMaintenance of MAP ≥ 65 with the use of vasopressors if needed
5.5. Obtain blood cultures prior to the administration of antibiotics Obtain blood cultures prior to the administration of antibiotics
6.6. Administer broad spectrum antibiotics within the first 3 hours of ED Administer broad spectrum antibiotics within the first 3 hours of ED admission and within the first 1 hour of non-ED admissionadmission and within the first 1 hour of non-ED admission
7.7. Achieve a central venous oxygen saturation (ScvO2) > 70% OR a Achieve a central venous oxygen saturation (ScvO2) > 70% OR a mixed central venous oxygen saturation M(SvO2) > 65% mixed central venous oxygen saturation M(SvO2) > 65%
Surviving Sepsis Campaign: http://www.survivingsepsis.org. 2012.
Background & Rationale On On January 1st, 2011 Kenmore Mercy Hospital Kenmore Mercy Hospital
implemented a modified sepsis bundle adapted from the implemented a modified sepsis bundle adapted from the University of Rochester Medical Center and Strong Memorial University of Rochester Medical Center and Strong Memorial Hospital in concordance with the Hospital in concordance with the Surviving Sepsis CampaignSurviving Sepsis Campaign
The modified sepsis bundle includes recommendations to The modified sepsis bundle includes recommendations to have the ICU team notified and involved in patient care as have the ICU team notified and involved in patient care as soon as a patient with severe sepsis or septic shock has soon as a patient with severe sepsis or septic shock has been identified in the emergency department been identified in the emergency department
It was postulated that there would be an improvement in It was postulated that there would be an improvement in morbidity and length of stay in this select patient population morbidity and length of stay in this select patient population at Kenmore Mercy Hospital after the implementation of 24-at Kenmore Mercy Hospital after the implementation of 24-hour critical care coverage and the use of the modified hour critical care coverage and the use of the modified sepsis bundle sepsis bundle
Design
A case-comparison retrospective analysisA case-comparison retrospective analysis
Comparison of patients admitted with a Comparison of patients admitted with a diagnosis of severe sepsis and/or septic diagnosis of severe sepsis and/or septic shock prior to and following the shock prior to and following the implementation of the protocol with 24 implementation of the protocol with 24 in-house critical care coveragein-house critical care coverage
Institutional review board approvalInstitutional review board approval
Design Inclusion criteriaInclusion criteria
– The fulfillment of SIRS (systemic inflammatory The fulfillment of SIRS (systemic inflammatory response syndrome), ANDresponse syndrome), AND
– Identifiable source of infection, ANDIdentifiable source of infection, AND– A systolic blood pressure no greater than 90 A systolic blood pressure no greater than 90
mmHg on arrival or after a crystalloid-fluid mmHg on arrival or after a crystalloid-fluid challenge, ORchallenge, OR
– Blood lactate concentration ≥ 19.8 mg/dL (4 Blood lactate concentration ≥ 19.8 mg/dL (4 mmol/L), ORmmol/L), OR
– Evidence of acute end-organ dysfunctionEvidence of acute end-organ dysfunction
Rivers E, Nguyen B, Havstad S, et al. Rivers E, Nguyen B, Havstad S, et al. Early Goal-directed Therapy in the Treatment of Severe Sepsis Early Goal-directed Therapy in the Treatment of Severe Sepsis and Septic Shock. and Septic Shock. New England Journal of MedicineNew England Journal of Medicine. 2001; 345(19), 1368-1377.. 2001; 345(19), 1368-1377.
Design Exclusion criteria Exclusion criteria
– age < 18 yearsage < 18 years– pregnancypregnancy– acute cerebral vascular accident (as a primary diagnosis)acute cerebral vascular accident (as a primary diagnosis)– acute coronary syndrome (as a primary diagnosis)acute coronary syndrome (as a primary diagnosis)– status asthmaticusstatus asthmaticus– cardiac dysrhythmia (as a primary diagnosis)cardiac dysrhythmia (as a primary diagnosis)– contraindication to central venous catheterizationcontraindication to central venous catheterization– active gastrointestinal hemorrhage (as a primary diagnosis)active gastrointestinal hemorrhage (as a primary diagnosis)– seizure on arrivalseizure on arrival– drug overdosedrug overdose– Do Not Resuscitate (DNR) order on arrival or within the first 72 Do Not Resuscitate (DNR) order on arrival or within the first 72
hours of admissionhours of admission
Rivers E, Nguyen B, Havstad S, et al. Rivers E, Nguyen B, Havstad S, et al. Early Goal-directed Therapy in the Treatment of Severe Sepsis Early Goal-directed Therapy in the Treatment of Severe Sepsis and Septic Shock. and Septic Shock. New England Journal of MedicineNew England Journal of Medicine. 2001; 345(19), 1368-1377.. 2001; 345(19), 1368-1377.
Design
Methods
Independent sample t-test analysisIndependent sample t-test analysis
Utilizing IBM Statistical Package for the Utilizing IBM Statistical Package for the Social Sciences (SPSS) softwareSocial Sciences (SPSS) software
Help from a statistically inclined Help from a statistically inclined colleague! colleague!
Outcome Measures
PrimaryPrimary– Absolute APACHE-II at 72 hoursAbsolute APACHE-II at 72 hours– Net reduction in APACHE-II at 72 hoursNet reduction in APACHE-II at 72 hours
SecondarySecondary– Hospital Length of Stay (days)Hospital Length of Stay (days)– ICU Length of Stay (days)ICU Length of Stay (days)– Emergency Department Length of Stay (hours)Emergency Department Length of Stay (hours)– Volume infused in the first 6 and 12 hoursVolume infused in the first 6 and 12 hours– Volume infused over the first 24 hoursVolume infused over the first 24 hours– MAP at 24 hoursMAP at 24 hours
APACHE-II ScoreAPACHE-II Score
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. "APACHE II: a severity of disease classification Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. "APACHE II: a severity of disease classification system". system". Critical Care MedicineCritical Care Medicine 13 (10): 818–29. 13 (10): 818–29.
Results Without Protocol (N=95) With Protocol (N=53)
Age (years) 68.2 65.1
Weight on Arrival (kg) 78.4 85.6
Temperature on Arrival (˚C) 37.6 37.9
Heart Rate on Arrival (bpm) 106 106
24 Hour Input (liters) 6.05 8.42
24 Hour Ouput (liters) 2.11 2.34
MAP at 24 Hours 82 84.7
Percentage Receiving Central Line 49.4% 98.1%
*Mortality 25.3% (24/95) 20.7% (11/53)
*Underpowered to detect mortality
Results
Without Protocol (N=95)
With Protocol (N=53) p Value
APACHE-II at Arrival 17.5 21.5 <0.00001
Absolute APACHE-II at 72 Hours 15.7 14.9 0.419
Net Reduction in APACHE at 72 Hours
1.8 6.5 <0.00001
ED Length of Stay (Hours) 4.51 3.51 0.002
ICU Length of Stay (Days) 7.2 6.1 0.296
Hospital Length of Stay (Days) 13.6 10.7 0.046
Input in first 6 Hours (liters) 1.62 2.23 0.002
Input in first 12 Hours (liters) 3.13 5.15 <0.00001
Results
Without Protocol (N=95)
With Protocol (N=53) p Value
APACHE-II at Arrival 17.5 21.5 <0.00001
Absolute APACHE-II at 72 Hours 15.7 14.9 0.419
Net Reduction in APACHE at 72 Hours
1.8 6.5 <0.00001
ED Length of Stay (Hours) 4.51 3.51 0.002
ICU Length of Stay (Days) 7.2 6.1 0.296
Hospital Length of Stay (Days) 13.6 10.7 0.046
Input in First 6 Hours (liters) 1.62 2.23 0.002
Input in First 12 Hours (liters) 3.13 5.15 <0.00001
Results
1.8
6.5
0 1 2 3 4 5 6 7
APACHE-II Point Reduction
Without Protocol (N=95)
With Protcol (N=53)
Comparison in the Net Reduction of the APACHE-II Score at 72 Hours (p < 0.00001)
Results
4.513.51
0
1
2
3
4
5
Hours
Without Protocol (N=95) With Protcol (N=53)
Comparison in ED Length of Stay (p = 0.002)
Results
13.6
10.7
0
2
4
6
8
10
12
14
Hospital Days
Without Protocol (N=95) With Protcol (N=53)
Comparison in Hospital Length of Stay (p = 0.046)
Results Mean p Value
Age (Years)
Mortality (N=35) 76.4<0.001
No Mortality (N=113) 63.4
APACHE-II at 72
Mortality (N=35) 20.4<0.001
No Mortality (N=113) 13.8
ED Length of Stay (Hours)
Mortality (N=35) 4.20.98
No Mortality (N=113) 4.1
ICU Length of Stay (Days)
Mortality (N=35) 8.90.11
No Mortality (N=113) 6.2
Hospital Length of Stay (Days)
Mortality (N=35) 14.90.19
No Mortality (N=113) 11.9
Results Mean p Value
Age (Years)
Mortality (N=35) 76.4<0.001
No Mortality (N=113) 63.4
APACHE-II at 72
Mortality (N=35) 20.4<0.001
No Mortality (N=113) 13.8
ED Length of Stay (Hours)
Mortality (N=35) 4.20.98
No Mortality (N=113) 4.1
ICU Length of Stay (Days)
Mortality (N=35) 8.90.11
No Mortality (N=113) 6.2
Hospital Length of Stay (Days)
Mortality (N=35) 14.90.19
No Mortality (N=113) 11.9
Time (Hours) 0 6 12 18 24
Temperature ˚C
No Protocol (N=95) 37.5 37.3 37.5 37.5 37.5
Protocol (N=53) 37.9 37.4 37.6 37.7 37.5
Heart Rate (bpm)
No Protocol (N=95) 106 98 97 94 95
Protocol (N=53) 106 96 93 91 93
Input (liters)
No Protocol (N=95) 0.00 1.67 3.13 4.70 6.05
Protocol (N=53) 0.00 2.23 5.15 6.96 8.42
Output (liters)
No Protocol (N=95) 0.00 0.42 1.01 1.56 2.10
Protocol (N=53) 0.00 0.36 0.96 1.60 2.34
MAP
No Protocol (N=95) 79.0 76.9 76.0 76.4 78.2
Protocol (N=53) 75.0 73.6 75.6 74.1 78.8
Time (Hours) 0 6 12 18 24
Temperature ˚C
No Protocol (N=95) 37.5 37.3 37.5 37.5 37.5
Protocol (N=53) 37.9 37.4 37.6 37.7 37.5
Heart Rate (bpm)
No Protocol (N=95) 106 98 97 94 95
Protocol (N=53) 106 96 93 91 93
Input (liters)
No Protocol (N=95) 0.00 1.67 3.13 4.70 6.05
Protocol (N=53) 0.00 2.23 5.15 6.96 8.42
Output (liters)
No Protocol (N=95) 0.00 0.42 1.01 1.56 2.10
Protocol (N=53) 0.00 0.36 0.96 1.60 2.34
MAP
No Protocol (N=95) 79.0 76.9 76.0 76.4 78.2
Protocol (N=53) 75.0 73.6 75.6 74.1 78.8
Conclusions
The patients in the protocol arm had a The patients in the protocol arm had a significantly higher APACHE-II on arrival significantly higher APACHE-II on arrival (21.5 vs 17.5, p<0.00001)
There was a significant difference in the There was a significant difference in the net reduction in the APACHE-II score at net reduction in the APACHE-II score at 72 hours in the protocol arm 72 hours in the protocol arm (6.5 vs 1.8, p<0.00001) but no significant but no significant difference in the absolute APACHE-II difference in the absolute APACHE-II score at 72 hours score at 72 hours (14.9 vs 15.7, (14.9 vs 15.7, p=0.419)p=0.419)
Conclusions
The use of a sepsis bundle and protocol The use of a sepsis bundle and protocol significantly reduced the emergency department significantly reduced the emergency department length of stay by length of stay by 60 minutes (p=0.002)60 minutes (p=0.002)
The use of a sepsis bundle and protocol The use of a sepsis bundle and protocol significantly reduced the hospital length of stay by significantly reduced the hospital length of stay by 2.9 days (p=0.046)2.9 days (p=0.046)
The fluid input for the first 6 & 12 hours was The fluid input for the first 6 & 12 hours was significantly greater in the protocol vs the no significantly greater in the protocol vs the no protocol arms protocol arms (p=0.002 & p<0.00001, (p=0.002 & p<0.00001, respectivley)respectivley)
Discussion and Considerations
•19 of the 78 charts identified (24 percent) after the implementation of the sepsis bundle failed to follow the protocol
•These are missed opportunities to improve the patient’s APACHE-II and significantly reduce their ED & Hospital lengths of stay
Discussion and Considerations
The data included out layers in both arms that The data included out layers in both arms that may have actually skewed the results in favor may have actually skewed the results in favor non-significancenon-significance
However, these were still included in the However, these were still included in the analysis in order to preserve the integrity of the analysis in order to preserve the integrity of the datadata
Despite the out layers, hospital and emergency Despite the out layers, hospital and emergency department length of stay were still found to be department length of stay were still found to be significantly reducedsignificantly reduced
Discussion and Considerations
Underpowered to detect mortality between the Underpowered to detect mortality between the two armstwo arms
Analysis of the entire population reflects what we Analysis of the entire population reflects what we already know:already know:– The higher the APACHE-II, the greater the mortality The higher the APACHE-II, the greater the mortality (20.4 vs.
13.8, p<0.001)– The older the patient, the greater the mortality The older the patient, the greater the mortality (76.4 vs 63.4, (76.4 vs 63.4,
p<0.001)p<0.001)
APACHE-II has only been validated as a predictor APACHE-II has only been validated as a predictor of mortality at admission and not as a dynamic of mortality at admission and not as a dynamic predictor of mortality. However, APACHE-II is predictor of mortality. However, APACHE-II is routinely used in the literature as a severity of routinely used in the literature as a severity of illness index in a dynamic fashion (see Rivers et illness index in a dynamic fashion (see Rivers et al)al)
Discussion and Considerations
Statistical considerationsStatistical considerations– p-Value of < 0.00001 is not always a good p-Value of < 0.00001 is not always a good
thingthing
– As in the case of the net reduction of the As in the case of the net reduction of the APACHE-II and APACHE-II at arrival having APACHE-II and APACHE-II at arrival having p<0.00001p<0.00001
– Can either mean the data is truly highly Can either mean the data is truly highly significant or there is the presence of a Type-I significant or there is the presence of a Type-I (alpha) error(alpha) error e.g. Falsely rejecting the null hypothesise.g. Falsely rejecting the null hypothesis
Discussion and Considerations
Can the principles learned from early Can the principles learned from early goal directed therapy be executed in a goal directed therapy be executed in a small community based hospital and small community based hospital and have meaningful outcomes?have meaningful outcomes?
–YES !!!!!!!!!!!!!!!!YES !!!!!!!!!!!!!!!!
QuestionsQuestions
References1.1. Schmidt GA, Mandel J, Parsons, PE, et al. Management of Severe Sepsis and Septic Schmidt GA, Mandel J, Parsons, PE, et al. Management of Severe Sepsis and Septic
Shock in Adults. UpToDate®. February 3, 2010.Shock in Adults. UpToDate®. February 3, 2010.
2.2. Shapiro N, Howell MD, Talmor D. Implementation and Outcomes of the Multiple Urgent Shapiro N, Howell MD, Talmor D. Implementation and Outcomes of the Multiple Urgent Sepsis Therapies (MUST) Protocol. Sepsis Therapies (MUST) Protocol. Critical Care MedicineCritical Care Medicine. 2006. 34(4), 1025-32.. 2006. 34(4), 1025-32.
3.3. Dellinger RP, Levy, MM, Carlet JM, et. al. Surviving Sepsis Campaign: International Dellinger RP, Levy, MM, Carlet JM, et. al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008. Guidelines for Management of Severe Sepsis and Septic Shock: 2008. Critical Care Critical Care MedicineMedicine. 2008.. 2008.
4.4. The Surviving Sepsis Campaign: The Surviving Sepsis Campaign: http://www.survivingsepsis.orghttp://www.survivingsepsis.org. 2012. . 2012.
5.5. Rivers E, Nguyen B, Havstad S, et al. Rivers E, Nguyen B, Havstad S, et al. Early Goal-directed Therapy in the Treatment of Early Goal-directed Therapy in the Treatment of Severe Sepsis and Septic Shock. Severe Sepsis and Septic Shock. New England Journal of MedicineNew England Journal of Medicine. 2001; 345(19), . 2001; 345(19), 1368-1377.1368-1377.
6.6. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. "APACHE II: a severity of Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. "APACHE II: a severity of disease classification system". disease classification system". Critical Care MedicineCritical Care Medicine 13 (10): 818–29. 13 (10): 818–29.
7.7. Bryan-Brown CW, Dracup K. Procrastination is the Thief of Time: Surviving Guidelines. Bryan-Brown CW, Dracup K. Procrastination is the Thief of Time: Surviving Guidelines. American Journal of Critical Care.American Journal of Critical Care. 2004; 14(4), 287-289. 2004; 14(4), 287-289.
8.8. Talmore D, Greenberg D, Howell M et al. The Cost and Cost-effectiveness of an Talmore D, Greenberg D, Howell M et al. The Cost and Cost-effectiveness of an Integrated Sepsis Treatment Protocol. Integrated Sepsis Treatment Protocol. Critical Care MedicineCritical Care Medicine. 2008; 36(4), 1168-1174. . 2008; 36(4), 1168-1174.